Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

Leiomyosarcoma (LMS) is characterized by high genomic complexity, and to date, no specific targeted therapy is available. In a genome-wide approach, we profiled genomic aberrations in a small cohort of eight primary tumours, two relapses, and eight metastases across nine different patients. We ident...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sarcoma
Autors principals: Böhm, Michael J., Marienfeld, Ralf, Jäger, Daniela, Mellert, Kevin, von Witzleben, Adrian, Brüderlein, Silke, Wittau, Mathias, von Baer, Alexandra, Schultheiss, Markus, Mayer-Steinacker, Regine, Rücker, Frank G., Möller, Peter, Bullinger, Lars, Barth, Thomas F. E.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360577/
https://ncbi.nlm.nih.gov/pubmed/30804704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3914232
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars